There are multiple potential reasons for patients not responding to ICIs: lack of CD8+ T cell tumor infiltration, low tumor cell mutational burden, and low IFNγ signature, or so-called ‘cold’ TME [174]. The gene discussed is IFNG; the disease is neoplasm.